Antibody reagents for immunologic analysis of under-represented mammalian models
Active Definitive Contract Awarded Last action
- Contract number
- 75N93025C00019
- Awardee
-
Integral Molecular Inc. UEI DY9KSWE8EJB8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,500,000
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20251 · Posted Jul 18, 2024
- Contract value 100% obligated
- $1,500,000.00 Current and potential, with all options
- Completion date 47% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,500,000.00 Firm Fixed Price Definitive Contract to Integral Molecular Inc., a small business biotechnology company, for the development of antibody reagents to support immunologic analysis of underrepresented mammalian models. This contract is part of the Small Business Innovation Research (SBIR) Program Phase II. Integral Molecular specializes in membrane protein research and has received prior contracts and grants from various federal agencies, including NIAID, the National Cancer Institute, and the Department of the Army, to provide a range of biomedical research services and products. The contract has a period of performance through May 31, 2028.
Quick answers
Who was awarded contract 75N93025C00019?
75N93025C00019 was awarded to Integral Molecular Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 1, 2025.
How much is contract 75N93025C00019 worth?
The government has obligated $1,500,000 on 75N93025C00019.
Was contract 75N93025C00019 competed?
The extent of competition for 75N93025C00019 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award